{"id":"W1877911682","doi":"10.1038/nm.3910","title":"NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma","year":2015,"lang":"en","type":"article","venue":"Nature Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":848,"is_retracted":false,"has_abstract":false,"ca_institutions":"Carleton University","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Cytotoxic T cell; Antigen; Medicine; Multiple myeloma; Immunology; T-cell receptor; Chimeric antigen receptor; Cancer research; Bone marrow; T cell; Immune system; Biology; In vitro","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0176906565937794,"score_gpt":0.2984853652944252,"score_spread":0.2807947087006458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}